National Heart, Lung, and Blood Institute; Notice of Meeting, 30611-30612 [2021-12092]

Download as PDF Federal Register / Vol. 86, No. 109 / Wednesday, June 9, 2021 / Notices Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, 301–594–2242, jerkinsa@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: June 3, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Maximizing Investigators’ Research Award B Study Section. Date: July 1–2, 2021. Time: 9:00 a.m. to 8:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sudha Veeraraghavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4166, MSC 7846, Bethesda, MD 20892, (301) 827– 5263, sudha.veeraraghavan@nih.gov. Information is also available on the Institute’s/Center’s home page: https:// public.csr.nih.gov/StudySections/DBIB/ BCMB, where an agenda and any additional information for the meeting will be posted when available. 18:13 Jun 08, 2021 Jkt 253001 Dated: June 3, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–12027 Filed 6–8–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting [FR Doc. 2021–12033 Filed 6–8–21; 8:45 am] VerDate Sep<11>2014 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Notice is hereby given of a change in the meeting of the Child Psychopathology and Developmental Disabilities Study Section, June 17, 2021, 09:00 a.m. to June 18, 2021, 08:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on May 20, 2021, 86 FR 27459. Kirk Thompson, Ph.D., Kirk.Thompson@ nih.gov, (240) 498–9897, will be the new Contact person, replacing Katherine Morasch as Scientific Review Officer. The meeting date and location remain the same. The meeting is closed to the public. Dated: June 3, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. 30611 applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Multi-Disciplinary Machineassisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional). Date: July 14, 2021. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nakia C. Brown, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892, 301–827–4905, brownnac@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: June 4, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–12093 Filed 6–8–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2021–12028 Filed 6–8–21; 8:45 am] National Heart, Lung, and Blood Institute; Notice of Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Asthma Education Prevention Program Coordinating Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Asthma Education Prevention Program Coordinating Committee. Date: July 9, 2021. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and discuss asthma guidelines and implementation; updates on current and future activities. Discussion on programmatic updates. E:\FR\FM\09JNN1.SGM 09JNN1 30612 Federal Register / Vol. 86, No. 109 / Wednesday, June 9, 2021 / Notices Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Virtual Access: Please visit the link below to join the webinar: https:// nih.zoomgov.com/j/1611655505? pwd=RjBSc0xqbTl0S003eVYx a011eTU1Zz09. Event Passcode: 576619. Call-in: 1–669–254–5252 or 1–646–828–7666. Webinar ID: 161 165 5505. Passcode: 576619. International numbers available: https:// nih.zoomgov.com/u/avaNgcx8v. Contact Person: Susan T. Shero, R.N., M.S., Executive Secretary, National Asthma Education and Prevention Program Coordinating Committee, National Heart, Lung and Blood Institute, 6075 Rockledge Drive, Suite 6197, Bethesda, MD 20892, 301– 496–1051, Susan.shero@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nhlbi.nih.gov/advisory-and-peerreview-committees/national-asthmaeducation-andprevention-programcoordinating, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: June 4, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket Number USCG–2021–0238] Consolidation of Redundant Coast Guard Boat Stations Coast Guard, DHS. Request for comments. AGENCY: We are requesting your comments on the planned consolidation of redundant Coast Guard boat stations. Many stations were established at a time when boats lacked engines and were powered by oars and paddles. With modern boat operating speeds and improved direction finding technology, many calls for Coast Guard assistance can be responded to by multiple units significantly faster than when these boat lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:13 Jun 08, 2021 Jkt 253001 I. Table of Abbreviations CFR Code of Federal Regulations DHS Department of Homeland Security GAO Government Accountability Office [FR Doc. 2021–12092 Filed 6–8–21; 8:45 am] ACTION: stations were first established. The combination of significantly improved response times, along with an overall reduction in rescue calls due to boating safety improvements throughout the nation, has resulted in a number of boat stations becoming redundant. This consolidation will result in a more robust response system by increasing staffing levels and capacity at select nearby boat stations. Such a consolidation creates synergy and more opportunities for boat operators to properly train instead of missing training opportunities while standing ready to respond to calls that do not come. DATES: Written comments and related material may be submitted to the Coast Guard personnel specified below. Your comments and related material must reach the Coast Guard on or before August 3, 2021. ADDRESSES: You may submit comments identified by docket number USCG– 2021–0238 using the Federal rulemaking portal at https:// www.regulations.gov. See the ‘‘Public Participation and Request for Comments’’ portion of the SUPPLEMENTARY INFORMATION section for further instructions on submitting comments. FOR FURTHER INFORMATION CONTACT: For information about this document, please call or email Todd Aikins, Coast Guard Office of Boat Forces, 202–372–2463, todd.r.aikins@uscg.mil. SUPPLEMENTARY INFORMATION: II. Background and Purpose In October of 2017, the GAO issued report GAO–18–9, titled ‘‘Actions Needed to Close Stations Identified as Overlapping and Unnecessarily Duplicative.’’ This GAO report, a copy of which is in the docket for this notice, recommends the consolidation of 18 boat stations. Due to environmental and operational factors, the Coast Guard is not considering all 18 boat stations identified in the GAO report for consolidation this year. Instead, we anticipate consolidating four stations, with implementation notionally scheduled for fiscal year 2022. These stations have been identified because there are other units nearby capable of responding to cases in these areas, and because these four stations respond to a low number of cases. We do not anticipate any adverse effect on Coast Guard response capability. We expect PO 00000 Frm 00027 Fmt 4703 Sfmt 9990 enhanced proficiency of boat operators as well as a less complicated response system. III. Discussion The following seasonal stations, Stations-Small Scituate, MA; Holland, MI; North Superior, MN; and Beach Haven, NJ; have been identified for consolidation with neighboring stations. These are seasonal stations are detached subunits of larger parent stations. This consolidation is expected to result in a more robust response system by increasing staffing levels and capacity at select nearby boat stations. Such a consolidation creates synergy and more opportunities for boat operators to properly train. IV. Public Participation and Request for Comments We encourage you to submit comments through the Federal portal at https://www.regulations.gov. If your material cannot be submitted using https://www.regulations.gov, contact the person in the FOR FURTHER INFORMATION CONTACT section of this document for alternate instructions. In your submission, please include the docket number for this notice and provide a reason for each suggestion or recommendation. We will review all comments received, but we may choose not to post off-topic, inappropriate, or duplicate comments that we receive. We accept anonymous comments. Comments we post to https:// www.regulations.gov will include any personal information you have provided. For more about privacy and submissions in response to this document, see DHS’s eRulemaking System of Records notice (85 FR 14226, March 11, 2020). Documents mentioned in this notice as being available in the docket, and public comments, will be in our online docket at https://www.regulations.gov and can be viewed by following that website’s instructions. John W. Mauger, Rear Admiral, U.S. Coast Guard, Assistant Commandant for Capability. [FR Doc. 2021–12105 Filed 6–8–21; 8:45 am] BILLING CODE 9110–04–P E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 86, Number 109 (Wednesday, June 9, 2021)]
[Notices]
[Pages 30611-30612]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12092]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Asthma 
Education Prevention Program Coordinating Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Asthma Education Prevention Program 
Coordinating Committee.
    Date: July 9, 2021.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and discuss asthma guidelines and 
implementation; updates on current and future activities. Discussion 
on programmatic updates.

[[Page 30612]]

    Place: National Institutes of Health, 6100 Executive Boulevard, 
Rockville, MD 20852 (Virtual Meeting).
    Virtual Access: Please visit the link below to join the webinar: 
https://nih.zoomgov.com/j/1611655505?pwd=RjBSc0xqbTl0S003eVYxa011eTU1Zz09. Event Passcode: 
576619. Call-in: 1-669-254-5252 or 1-646-828-7666. Webinar ID: 161 
165 5505. Passcode: 576619. International numbers available: https://nih.zoomgov.com/u/avaNgcx8v.
    Contact Person: Susan T. Shero, R.N., M.S., Executive Secretary, 
National Asthma Education and Prevention Program Coordinating 
Committee, National Heart, Lung and Blood Institute, 6075 Rockledge 
Drive, Suite 6197, Bethesda, MD 20892, 301-496-1051, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person. Information is also available 
on the Institute's/Center's home page: https://www.nhlbi.nih.gov/advisory-and-peer-review-committees/national-asthma-education-andprevention-program-coordinating, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: June 4, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-12092 Filed 6-8-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.